Genetic variation and cardiac pharmacotherapy
Publisher
Springer Netherlands
Reference70 articles.
1. Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol. 1979;16:183–7.
2. Mahgoub A, Idle J, Dring L, Lancaster R, Smith RL. Polymorphic hydroxylation of debrisoquine in man. Lancet. 1977;2:584–6.
3. Eichelbaum M, Gross A. The genetic polymorphism of debrisoquine/sparteine metabolism-clinical aspects. Pharmacol Ther. 1990;46:377–94.
4. Nebert D, Gonzalez F. P450 genes. Their structure, evolution and regulation. Annu Rev Biochem. 1987;56:945–93.
5. Eichelbaum M, Bertilsson L, Sawe J, Zekorn C. Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities. Clin Pharmacol Ther. 1982;31:184–6.